Kostas Tzelepis
@TzelepisLab
Wellcome Trust Investigator @Cambridge_Uni. New RNA biology. Discovery of novel epitranscriptomic targets and treatments. Bench-to-clinic research.
Very proud to announce our latest paper @nature showing the development and characterisation of the first-in-class catalytic inhibitor of METTL3 against AML. A superb collaboration between our lab (@TheMilnerInst, @sangerinstitute), @storm_tx and @TKLABUK disq.us/t/3wgxg9e
My lab is recruiting a talented post-doc researcher interested in tRNA modifications - mRNA translation & immune oncology. We identify new therapeutic vulnerabilities in cancer using various - ambitious - approaches. Please spread 🤩 and apply ASAP 😉 @Translacore
It's that time of year - roll call for all new #cancer PIs who just started or who are about to start their labs! Please say hi and what you work on so I can follow you if I don't already! 😃 #NewPI
5days until our London mini RNA symposium at @QMBCI on 16th July. We have put together excellent programme incl. talks by @TzelepisLab @MadziaCrossley Vikram Paralkar @hannahjlawson and early-career researchers. See you all next week . Programme 👇 thanks @RNASociety for support
Join us for an in-person mini-symposium to discuss several topics at the interface of RNA biology and Cancer @QMBCI on 16th July. Free to come. Pizza and drink to network! @LondonRNAClub
2 weeks to go! Come and join us for this exciting half of day with a great lineup. Free to attend. No need to register. Looking forward to seeing you all!
Join us for an in-person mini-symposium to discuss several topics at the interface of RNA biology and Cancer @QMBCI on 16th July. Free to come. Pizza and drink to network! @LondonRNAClub
From targeting a new marker in AML to uncovering the immune system’s role in MPNs and finding a gentler combo for childhood leukaemia - our funded researchers have been busy! 🧪👏 Here are just a few publication highlights 👉 leukaemiauk.org.uk/stories/resear…
The Institute of Cancer Research is hiring a new Group Leader! A unique opportunity to establish your own research group at one of the UK’s leading cancer institutes. Competitive package, strong senior support, and access to world-class facilities. nature.com/naturecareers/…
ASH has made an unprecedented investment of more than $12 million. Including ~$9 million increase in award funding. Total awards commitment of more than $20 million over the next 12 months....providing support for an additional 600+ awardees at all career stages. @ASH_hematology
ASH is committing more than $12 million to address research funding challenges and support the next generation of hematologists. Learn more: ow.ly/sK3050W735W #Fight4Hematology
Great news @storm_tx!! Off we go🔥🔥 prnewswire.co.uk/news-releases/…
We're hiring! Join our team at Oxford to work on cutting-edge research in haematology and myeloproliferative neoplasms. Apply here 👉 my.corehr.com/pls/uoxrecruit… Learn more about our work 👉 imm.ox.ac.uk/research/resea… @Ludwig_Cancer @MRC_WIMM #AcademicJobs #Haematology #MPN #Oxford
👇🏻👇🏻👇🏻
Join us for an in-person mini-symposium to discuss several topics at the interface of RNA biology and Cancer @QMBCI on 16th July. Free to come. Pizza and drink to network! @LondonRNAClub
We're incredibly proud to have backed this groundbreaking study by our funded researcher @TzelepisLab and team! It could pave the way for more precise, and less toxic, treatments for AML patients facing relapse. 👏 express.co.uk/news/uk/205335…
Check out the latest @NatureBiotech Research Briefing regarding our recent work on therapeutic targeting of cell surface RBPs in cancer 🔥🔥 nature.com/articles/s4158…
👇🏻👇🏻🔥🔥
GLYCAN ATLASSING: NANOSCALE ANALYSIS OF GLYCOCALYX ARCHITECTURE ENABLES FUNCTIONAL TRACING OF CELL STATE 🍭🔬🧬 Don’t judge a book by its cover-judge a cell by its cover! We can now trace how cell state is encoded in glycocalyx state #glycotime #microscopy tinyurl.com/536rvpxr
👇🏻👇🏻👇🏻👇🏻
Just under two weeks to submit your work for presentation. Travel grants for trainees with top scoring abstracts. Check out the program to see the outstanding environment in which you would be showcasing your project as well as the training/networking activities.
ICYMI 🔥
An RNA-binding protein on leukemia cells provides an effective target for treatment in mouse models, according to a paper in @NatureBiotech. go.nature.com/3YR25m7
An RNA-binding protein on leukemia cells provides an effective target for treatment in mouse models, according to a paper in @NatureBiotech. go.nature.com/3YR25m7
Please join our colleagues Maria Eleftheriou & Eliza Yankova #AACR2025 to learn more about our lab’s collaborative work on the identification of novel epitrancriptomic therapies in the wider field of oncology. Join Maria on Monday afternoon in the Developmental Origins and…
A breakthrough from our funded researcher @TzelepisLab and team! 💡 They've discovered a new target on AML cells - a protein called csNPM1 that’s normally hidden inside of cells, but appears on the surface of some cancer cells. 🔗 Read more: nature.com/articles/s4158…